• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
      -
      -
      -
        Visualized Analysis Export Evaluation Conclusion Evaluation Progress
        Show  
        Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
        JXSB2400012 ACZ885 canakinumab Injection Biological Products(1) Supplementary Application 2024-02-05 Novartis Pharma Stein AG;Novartis Pharma Schweiz AG view
        JXSB2300039 ACZ885注射液 canakinumab Injection Biological Products(2.2) Supplementary Application 2023-04-11 Novartis Pharma Stein AG;Novartis Pharma Schweiz AG view
        JXSB2300019 ACZ885 canakinumab Injection Biological Products(1) Supplementary Application 2023-02-21 Novartis Pharma Stein AG;Novartis Pharma Schweiz AG view
        JXSL2200063 ACZ885 canakinumab Injection Biological Products(2.2) Import Drug Application 2022-05-26 China Novartis Institutes For Biomedical Research Co Ltd;Novartis Pharma Schweiz AG view
        JXSL2200064 ACZ885 canakinumab Injection Biological Products(2.2) Import Drug Application 2022-05-26 China Novartis Institutes For Biomedical Research Co Ltd;Novartis Pharma Schweiz AG view
        JXSL2100046 ACZ885注射液 canakinumab Injection Biological Products(2.2) Import Drug Application 2021-04-01 诺华(中国)生物医学研究有限公司 China Novartis Institutes For Biomedical Research Co Ltd;Novartis Pharma Schweiz AG In Review 2021-03-31 view
        JXSL1800040 ACZ885 canakinumab Injection Biological Products Import Drug Application 2018-10-29 Novartis Pharma AG Novartis Pharma Schweiz AG In Review 2018-10-27 view
        JXSL1800042 ACZ885 canakinumab Injection Biological Products Import Drug Application 2018-10-29 Novartis Pharma AG Novartis Pharma Schweiz AG In Review 2018-10-27 view
        JXSL1800041 ACZ885 canakinumab Injection Biological Products Import Drug Application 2018-10-26 Novartis Pharma AG Novartis Pharma Schweiz AG In Review 2018-10-25 view
        JXSL1800043 ACZ885 canakinumab Injection Biological Products Import Drug Application 2018-10-26 Novartis Pharma AG Novartis Pharma Schweiz AG In Review 2018-10-25 view
        JXSL1800007 ACZ885 canakinumab Injection Biological Products Import Drug Application 2018-02-22 Novartis Pharma AG Novartis Pharma Schweiz AG Certificate Issued 2018-08-27 view
        JXSL1800006 ACZ885 canakinumab Injection Biological Products Import Drug Application 2018-02-22 Novartis Pharma AG Novartis Pharma Schweiz AG Certificate Issued 2018-08-27 view
        JXSL1600020 ACZ885 canakinumab Injection Biological Products Import Drug Application 2016-04-13 北京诺华制药有限公司 Beijing Novartis Pharma Co Ltd;Novartis Pharma Schweiz AG Certificate Issued 2017-10-16 view
        JXSL1600018 ACZ885 canakinumab Injection Biological Products Import Drug Application 2016-04-13 北京诺华制药有限公司 Beijing Novartis Pharma Co Ltd;Novartis Pharma Schweiz AG Certificate Issued 2017-10-16 view
        JXSL1100049 ACZ885 canakinumab Injection Biological Products Import Drug Application 2011-09-30 北京诺华制药有限公司 Beijing Novartis Pharma Co Ltd;Novartis Pharma Schweiz AG Certificate Issued 2012-06-08 view
        JXSL1100010 ACZ885 canakinumab Injection Biological Products Import Drug Application 2011-03-03 北京诺华制药有限公司 Beijing Novartis Pharma Co Ltd;Novartis Pharma Schweiz AG Certificate Issued 2012-05-28 view
        JXSL0900072 ACZ885 canakinumab Injection Biological Products Import Drug Application 2009-10-16 北京诺华制药有限公司 Beijing Novartis Pharma Co Ltd;Novartis Pharma Schweiz AG Certificate Issued 2010-11-23 view
        You can use the filter after selecting or entering the search conditions.
        Using filter may affect the loading speed.
        ×××××××××
        Contact usFeed-backServiceTop
        You can use the filter after selecting or entering the search conditions.
        Using filter may affect the loading speed.